AstraZeneca and YMCA of the USA Launch Five-Year Partnership to Expand Cancer Screening, Early Detection and Survivorship Support Across the U.S. AstraZeneca and YMCA of the USA (Y-USA) have announced…
New Reproducibility Standard Set for Breast Imaging Biomarkers QT Imaging Holdings, Inc., a medical device company focused on advancing breast health through radiation-free imaging technology, has reported new data characterizing…
EMD Serono Names Miguel Fernández Alcalde Head of Global Commercial Strategy, Appoints Monia Vial to Lead North America EMD Serono, the Healthcare business of Merck KGaA in the United States…
Anodyne Nanotech Raises $12.6 Million Series A to Advance Weekly GLP-1 Patch for Obesity and Expand Transdermal Drug Delivery Platform Anodyne Nanotech Inc., a clinical-stage biotechnology company focused on transforming…
CEL-SCI and Saudi Amarox Formalize Partnership at BIO 2026 to Advance Oncology Innovation in Saudi Arabia CEL-SCI Corporation announced that it has officially completed a formal signing ceremony with Saudi…
Javelin Biotech Publishes Multi-Tissue Chip and PBPK Study Showing Potential to Predict Human Drug Pharmacokinetics Without Animal Data Javelin Biotech has announced the publication of a new scientific study that…
HighRes and Waters Biosciences Partner to Bring Robotic Automation to Flow Cytometry Workflows HighRes has announced a strategic collaboration with Waters Biosciences aimed at expanding robotic automation capabilities for flow…
Merck KGaA Teams With Saturnus Bio to Build Precision Cardiology Portfolio for Rare Genetic Cardiomyopathies Merck KGaA, Darmstadt, Germany has entered a strategic research-stage collaboration with Saturnus Bio, a biotechnology…
Cynosure Lutronic’s XERF Surpasses 2,000 Installations Worldwide, Highlighting Growing Demand for Non-Invasive Skin Tightening Cynosure Lutronic has reached a new commercial milestone for XERF™, its multifrequency monopolar radiofrequency platform for…
VectorBuilder and MaxCyte Partner to Develop Next-Generation Non-Viral Gene Delivery Platform for Ex Vivo Cell Therapies VectorBuilder and MaxCyte have entered into a strategic partnership aimed at developing a next-generation…
Dexcom Expands Access to Glucose Biosensing With Pediatric Clearance for Stelo and New App Rollout Plans DexCom, Inc. is broadening its push into preventive and personalized metabolic health with a…
Vyriad Reshapes Executive Leadership Team as It Prepares for Next Phase of Growth in In Vivo CAR T and Viral Delivery Therapies Vyriad, Inc., a clinical-stage biotechnology company focused on…